Synapse - Andrew Zelenetz

Results (785)

Marker-controlled watershed for lymphoma segmentation in sequential CT images

Journal Article

Yan, J.; Zhao, B.; Wang, L.; Zelenetz, A.; Schwartz, L. H.
Medical Physics (2006)

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

Journal Article

O'Connor, O. A.; Heaney, M. L.; Schwartz, L.; Richardson, S.; Willim, R.; Macgregor-Cortelli, B.; Curly, T.; Moskowitz, C.; Portlock, C.; Horwitz, S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: A retrospective analysis of a uniformly-treated patient population

Journal Article

Liedtke, M.; Hamlin, P. A.; Moskowitz, C. H.; Zelenetz, A. D.
Annals of Oncology (2006)

Fulltext@MSK | Save

Pentostatin, cyclophosphamide, and rituximab is an active, well-tolerated regimen for patients with previously treated chronic lymphocytic leukemia

Journal Article

Lamanna, N.; Kalaycio, M.; Maslak, P.; Jurcic, J. G.; Heaney, M.; Brentjens, R.; Zelenetz, A. D.; Horgan, D.; Gencarelli, A.; Panageas, K. S.; more...
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma

Journal Article

Kewalramani, T.; Zelenetz, A. D.; Teruya-Feldstein, J.; Hamlin, P.; Yahalom, J.; Horwitz, S.; Nimer, S. D.; Moskowitz, C. H.
British Journal of Haematology (2006)

Fulltext@MSK | Save

Hodgkin disease/lymphoma: Clinical Practice Guidelines in Oncology™

Journal Article

Hoppe, R. T.; Advani, R. H.; Bierman, P. J.; Bloomfield, C. D.; Buadi, F.; Djulgegovic, B.; Forero, A.; Gordon, L. I.; Hernandez-Ilizaliturri, F. J.; Kaminski, M. S.; more...
Journal of the National Comprehensive Cancer Network (2006)

Fulltext@MSK | Save

Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas

Journal Article

Chen, W.; Houldsworth, J.; Olshen, A. B.; Nanjangud, G.; Chaganti, S.; Venkatraman, E. S.; Halaas, J.; Teruya-Feldstein, J.; Zelenetz, A. D.; Chaganti, R. S. K.
Blood (2006)

Fulltext@MSK | Save

Sequential radioimmunotherapy with tositumomab/iodine I131 tositumomab followed by CHOP chemotherapy for mantle cell lymphoma is a safe and highly effective regimen

Meeting Abstract

Zelenetz, A.; Donnelly, G.; Pandit-Taskar, N.; Humm, J.; Divgi, C.
Annals of Oncology (2005)

Fulltext@MSK | Save

Results of a phase 2 trial of HGS-ETR1 (Agonistic human monoclonal antibody to TRAIL receptor 1) in subjects with relapsed/refractory non-Hodgkin's lymphoma (NHL)